A 17-year-old girl with facial edema and weakness

Rachel Deschamps^{1

2}, Julie Couture^{3

4}, Aristides Hadjinicolaou^{5

6}, Claire M A LeBlanc^{5

6}

Affiliations

Editorial

Rachel Deschamps et al. Paediatr Child Health. 2018 Jul.

. 2018 Jul;23(4):241-244.

doi: 10.1093/pch/pxx209. Epub 2018 Jan 23.

Rachel Deschamps^{1

2}, Julie Couture^{3

4}, Aristides Hadjinicolaou^{5

6}, Claire M A LeBlanc^{5

6}

No abstract available

Keywords: Dermatomyositis; Edema; Macrophage activation syndrome; Weakness.

Figures

1. Sevigny GM, Mathes BM. Periorbital edema as the presenting sign of juvenile dermatomyositis. Pediatr Dermatol 1999;16(1):43–5. - PubMed
1. Huber AM, Mamyrova G, Lachenbruch PA, et al. ; Childhood Myositis Heterogeneity Collaborative Study Group Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 2014;66(5):732–40. - PMC - PubMed
1. Ruperto N, Pistorio A, Oliveira S, et al. ; Paediatric Rheumatology International Trials Organisation (PRINTO) Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: A randomised trial. Lancet 2016;387(10019):671–8. - PubMed
1. Atteritano M, David A, Bagnato G, et al. . Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci 2012;16(10):1414–24. - PubMed
1. Ravelli A, Magni-Manzoni S, Pistorio A, et al. . Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005;146(5):598–604. - PubMed